Researchers are reviewing and analyzing surgical and clinical outcomes of subjects who underwent POPE for end-stage achalasia, a sigmoid esophagus, or a redundant conduit that has been used to replace the esophagus. This data will help researchers determine the safety and efficacy of a novel minimally invasive treatment compared to invasive surgery.
Researchers will be collecting electronic medical data for subjects who have already undergone Per-oral Plication of the Esophagus (POPE) procedure. Subject characteristics, radiographic documentation, videos, procedural details, and subject reported outcomes would be collected. This data will be used for review and analysis to answer questions aimed in this study. Data collected from this study will be entered into a database that will be maintained for future research.
Study Type
OBSERVATIONAL
Enrollment
20
Patients who have undergone Per-oral Plication of the Esophagus (POPE) procedure.
Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Evaluate safety by assessment of adverse events of the novel minimally invasive treatment compared to invasive surgery.
Time frame: 01/01/2017-9/17/2018
Patient Reported Outcomes using the CONDUIT patient questionnaire.
Evaluate efficacy by reviewing patient reported outcomes of the novel minimally invasive treatment compared to invasive surgery.
Time frame: 01/01/2017-9/17/2018
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.